hiv lenacapavir - Search News

News

FDA Approves 1st Twice-a-Year HIV Prevention Shot

CBS News on MSN · 2d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

CNN on MSN · 2d

FDA approves twice-a-year injection for HIV prevention

A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug Administration to be used to prevent HIV.

Public Broadcasting Service (PBS) · 20h

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.

7m

NIH office to phase out HIV guidelines by next year

The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...

7hon MSN

FDA approves Yeztugo: Gilead's new twice-yearly HIV prevention injection

He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the ...

11h

USFDA Okays Lenacapavir: Affordable, Generic India-Made Drug Key To Boost Global HIV Prevention

While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...

The American Journal of Managed Care2d

Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...

Health Affairs3d

A Perfect Storm: “Gamechanger” HIV Prevention Medicine Launches In The Midst Of Health System And Public Health Cuts

This month, lenacapavir is expected to receive FDA approval for pre-exposure prophylaxis (PrEP). It could very well be that ...

4d

Gilead's HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report

Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results